How do the MHLW and PMDA collaborate in the oversight of pharmaceuticals in Japan?

The MHLW and PMDA collaborate by setting regulatory standards, conducting safety evaluations, and approving new drugs. MHLW formulates policies and guidelines, while the PMDA performs dossier reviews, scientific reviews, inspections, and post-market surveillance. Together, they ensure the safety, efficacy, and quality of pharmaceuticals in Japan.

Leave a Reply

You must be logged in to post a comment.